Use and outcome of minimally invasive pancreatic surgery in the European E-MIPS registry

  • Nicky van der Heijde
  • , Frederique L Vissers
  • , Alberto Manzoni
  • , Giuseppe Zimmitti
  • , Joaquim Balsells
  • , Frederik Berrevoet
  • , Bergthor Bjornsson
  • , Peter van den Boezem
  • , Ugo Boggi
  • , Svein O Bratlie
  • , Fernando Burdio
  • , Andrea Coratti
  • , Mathieu D'Hondt
  • , Carlos D Del Pozo
  • , Safi Dokmak
  • , Regis Fara
  • , Mehmet F Can
  • , Sebastiaan Festen
  • , Antonello Forgione
  • , Claus Fristrup
  • Sebastien Gaujoux, Bas Groot Koerkamp, Thilo Hackert, Igor E Khatkov, Tobias Keck, Hanna Seppänen, Daan Lips, Misha Luyer, Gabriella Pittau, Manuel Maglione, I Quintus Molenaar, Patrick Pessaux, Geert Roeyen, Olivier Saint-Marc, Santiago S Cabus, Hjalmar van Santvoort, George van der Schelling, Mario Serradilla-Martin, Francois-Regis Souche, Miguel Á Suarez Muñoz, Marco V Marino, Marc G Besselink, Mohammed Abu Hilal,

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

BACKGROUND: The European registry for minimally invasive pancreatic surgery (E-MIPS) collects data on laparoscopic and robotic MIPS in low- and high-volume centers across Europe.

METHODS: Analysis of the first year (2019) of the E-MIPS registry, including minimally invasive distal pancreatectomy (MIDP) and minimally invasive pancreatoduodenectomy (MIPD). Primary outcome was 90-day mortality.

RESULTS: Overall, 959 patients from 54 centers in 15 countries were included, 558 patients underwent MIDP and 401 patients MIPD. Median volume of MIDP was 10 (7-20) and 9 (2-20) for MIPD. Median use of MIDP was 56.0% (IQR 39.0-77.3%) and median use of MIPD 27.7% (IQR 9.7-45.3%). MIDP was mostly performed laparoscopic (401/558, 71.9%) and MIPD mostly robotic (234/401, 58.3%). MIPD was performed in 50/54 (89.3%) centers, of which 15/50 (30.0%) performed ≥20 MIPD annually. This was 30/54 (55.6%) centers and 13/30 (43%) centers for MIPD respectively. Conversion rate was 10.9% for MIDP and 8.4% for MIPD. Overall 90 day mortality was 1.1% (n = 6) for MIDP and 3.7% (n = 15) for MIPD.

CONCLUSION: Within the E-MIPS registry, MIDP is performed in about half of all patients, mostly using laparoscopy. MIPD is performed in about a quarter of patients, slightly more often using the robotic approach. A minority of centers met the Miami guideline volume criteria for MIPD.

Original languageEnglish
Pages (from-to)400-408
Number of pages9
JournalInternational Hepato-Pancreato Biliary Association.
Volume25
Issue number4
DOIs
Publication statusPublished - Apr 2023

Keywords

  • Humans
  • Laparoscopy/adverse effects
  • Minimally Invasive Surgical Procedures
  • Pancreas/surgery
  • Pancreatectomy/adverse effects
  • Pancreatic Neoplasms/surgery
  • Pancreaticoduodenectomy/adverse effects
  • Postoperative Complications/etiology
  • Registries
  • Robotic Surgical Procedures/adverse effects
  • Treatment Outcome

Fingerprint

Dive into the research topics of 'Use and outcome of minimally invasive pancreatic surgery in the European E-MIPS registry'. Together they form a unique fingerprint.

Cite this